Wenhui Ye Selected Research

Neoplasms (Cancer)

12/2023	A cisplatin and disulfiram co-loaded inclusion complex overcomes drug resistance by inhibiting cancer cell stemness in non-small cell lung cancer.
9/2006	Molecular characterization of the recombinant A-chain of a type II ribosome-inactivating protein (RIP) from Viscum album coloratum and structural basis on its ribosome-inactivating activity and the sugar-binding properties of the B-chain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenhui Ye Research Topics

Disease

2	Neoplasms (Cancer) 12/2023 - 09/2006
1	Lung Neoplasms (Lung Cancer) 12/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2021
1	Birth Weight (Birth Weights) 01/2019
1	Thyroiditis 10/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2015
1	Hemorrhage 11/2015

Drug/Important Bio-Agent (IBA)

2	S-allylmercapto-N-acetylcysteineIBA 01/2023 - 12/2021
1	Cisplatin (Platino)FDA LinkGeneric 12/2023
1	Disulfiram (Antabuse)FDA Link 12/2023
1	Therapeutic UsesIBA 12/2021
1	monodansylcadaverineIBA 12/2021
1	Pancreatic Elastase (Elastase)IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	InterleukinsIBA 10/2018
1	SaporinsIBA 09/2006
1	LectinsIBA 09/2006

Therapy/Procedure

1	Stents 11/2015